NATIONAL PSORIASIS FOUNDATION for NATIONAL PSORIASIS FOUNDATION
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
1. Urge Congress to support efforts that increase access to care for people with psoriasis and psoriasis arthritis by supporting H.R.1600: Patients' Access to Treatments Act of 2015. This bill limits copayments, coinsurance, and other costsharing and out-of-pocket expenses for so called specialty tier drugs. This bill will help ensure that people with psoriasis and other chronic conditions have access to the therapy that their health care provider determines is most appropriate for them. 2. Support efforts to facilitate research efforts on psoriasis and psoriatic arthritis within institutes at the NIH. 3. Urge Congress to support HR 6, the 21st Century Cures Act. 4. Working with the CDC's National Center for Health Statistics, a division of the CDC, to better understand the current and looming data on psoriasis and psoriatic arthritis held by the NCHS to inform our research agenda. 5. Urge Congress to support HR 2624/S.1488 Medicare Part D Beneficiary Appeals Fairness Act. Allows a Medicare part D eligible individual enrolled in the plan to request an exception to the tiered cost-sharing structure
| Lobbyist | Covered position, as disclosed |
|---|---|
| QUARDRICOS BERNARD DRISKELL | — |
| LEAH MCCORMICK HOWARD | — |
| SARA KOFMAN | — |
Budget/Appropriations BUD
FY16 Appropriations for Psoriatic Disease Allocate $1.2 million in the Fiscal Year (FY) 2014 Labor, Health and Human Services, Education and Related Agencies (LHHS) Appropriations bill to implement a public health agenda for psoriasis and psoriatic arthritis at the Centers for Disease Control and Prevention (CDC). With this funding, the CDCs National Center for Health Statistics (NCHS) could begin implementation of the first ever psoriasis and psoriatic arthritis public health agenda by developing survey instruments, which will: Increase the understanding of psoriasis, including the prevalence of the diseases and how age, sex, race, and ethnicity affect the course and burden of psoriasis; Study how differences in genetic and nongenetic factors, such as environmental exposure and lifestyle,contribute to the occurrence and severity of psoriasis and psoriatic arthritis; Examine the relationship of psoriasis to other serious diseases and develop public health strategies to reduce the burden of diseases and prevent the onset of comorbid conditions; and Gain insight into the long term impact of psoriasis and psoriatic arthritis.
| Lobbyist | Covered position, as disclosed |
|---|---|
| QUARDRICOS BERNARD DRISKELL | — |
| LEAH MCCORMICK HOWARD | — |
| SARA KOFMAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.